Literature DB >> 7635951

Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture.

M Phelan1, S P Perrine, M Brauer, D V Faller.   

Abstract

The molecular defect in sickle cell disease resides in the beta globin gene, with consequent defects in erythrocytes only, suggesting that the vascular occlusion and vasomotor instability which characterize this disease are the result of interactions between abnormal sickle erythrocytes and cells of the blood vessel wall. We explored whether sickle erythrocytes may have effects on vascular tone, exclusive of adhesion events. Exposure of human endothelial cells in culture to previously sickled sickle erythrocytes resulted in a four to eight-fold transcriptional induction of the gene encoding the potent vasoconstrictor endothelin-1 (ET-1). Unsickled sickle erythrocytes or normal erythrocytes exposed to "sickling" conditions had no effect on ET-1 gene induction. Contact of the sickled erythrocytes with the endothelium was not required. Elevations in the ET-1 transcript peaked at 3 h after exposure and persisted for up to 24 h. Four to sixfold increases in the amount of ET-1 peptide was released into the medium surrounding the endothelial cells after exposure to sickled sickle erythrocytes. This is the first demonstration of the regulation of gene expression in endothelial cells as a result of interaction with sickle cells, with induction of genes encoding vasoconstrictors. Furthermore, these findings suggest that sickle erythrocytes may have the capacity to affect local vasomotor tone directly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635951      PMCID: PMC185305          DOI: 10.1172/JCI118102

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.

Authors:  K Nishida; D G Harrison; J P Navas; A A Fisher; S P Dockery; M Uematsu; R M Nerem; R W Alexander; T J Murphy
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  The effect of probucol on the proliferation of cultured human umbilical vascular endothelial cells.

Authors:  T Tajika; Y Ono; K Ono; M Miura; Y Kyo
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

3.  Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells.

Authors:  M Mitsumata; R S Fishel; R M Nerem; R W Alexander; B C Berk
Journal:  Am J Physiol       Date:  1993-07

4.  Flow effects on prostacyclin production by cultured human endothelial cells.

Authors:  J A Frangos; S G Eskin; L V McIntire; C L Ives
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

5.  Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries.

Authors:  V M Miller; J C Burnett
Journal:  Am J Physiol       Date:  1992-07

6.  Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.

Authors:  S Kourembanas; L P McQuillan; G K Leung; D V Faller
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes.

Authors:  M Mosseri; A N Bartlett-Pandite; K Wenc; J M Isner; R Weinstein
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

8.  Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP.

Authors:  A M Malek; A L Greene; S Izumo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells.

Authors:  M J Kuchan; J A Frangos
Journal:  Am J Physiol       Date:  1993-01

10.  Increased shear stress leads to differential release of endothelin and ATP from isolated endothelial cells from 4- and 12-month-old male rabbit aorta.

Authors:  P Milner; P Bodin; A Loesch; G Burnstock
Journal:  J Vasc Res       Date:  1992 Nov-Dec       Impact factor: 1.934

View more
  23 in total

1.  Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.

Authors:  Robyn J Barst; Kamal K Mubarak; Roberto F Machado; Kenneth I Ataga; Raymond L Benza; Oswaldo Castro; Robert Naeije; Namita Sood; Paul S Swerdlow; Mariana Hildesheim; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-02-17       Impact factor: 6.998

2.  Endothelin-A Receptor Antagonism Retards the Progression of Murine Sickle Cell Nephropathy.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2017-04-25       Impact factor: 10.121

Review 3.  Pathophysiology of pulmonary hypertension in acute lung injury.

Authors:  Laura C Price; Danny F McAuley; Philip S Marino; Simon J Finney; Mark J Griffiths; Stephen John Wort
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-13       Impact factor: 5.464

Review 4.  The multifaceted role of ischemia/reperfusion in sickle cell anemia.

Authors:  Robert P Hebbel; John D Belcher; Gregory M Vercellotti
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

5.  Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease.

Authors:  Ramiro Juncos; Luis Juncos; Robert P Hebbel; Gregory M Vercellotti; Zvonimir S Katusic; Karl A Nath
Journal:  J Cardiovasc Pharmacol       Date:  2011-02       Impact factor: 3.105

6.  Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium.

Authors:  Rahima Zennadi; Ai Chien; Ke Xu; Milena Batchvarova; Marilyn J Telen
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

7.  Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Authors:  Nathalie Sabaa; Lucia de Franceschi; Philippe Bonnin; Yves Castier; Giorgio Malpeli; Haythem Debbabi; Ariane Galaup; Micheline Maier-Redelsperger; Sophie Vandermeersch; Aldo Scarpa; Anne Janin; Bernard Levy; Robert Girot; Yves Beuzard; Christophe Leboeuf; Annie Henri; Stéphane Germain; Jean-Claude Dussaule; Pierre-Louis Tharaux
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

8.  Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha.

Authors:  Nitin Patel; Caryn S Gonsalves; Punam Malik; Vijay K Kalra
Journal:  Blood       Date:  2008-04-14       Impact factor: 22.113

9.  Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Authors:  Natasha M Rogers; Mingyi Yao; John Sembrat; M Patricia George; Heather Knupp; Mark Ross; Maryam Sharifi-Sanjani; Jadranka Milosevic; Claudette St Croix; Revathi Rajkumar; Maria G Frid; Kendall S Hunter; Luciano Mazzaro; Enrico M Novelli; Kurt R Stenmark; Mark T Gladwin; Ferhaan Ahmad; Hunter C Champion; Jeffrey S Isenberg
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

10.  Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species.

Authors:  J Brett Heimlich; Joshua S Speed; Paul M O'Connor; Jennifer S Pollock; Tim M Townes; Steffen E Meiler; Abdullah Kutlar; David M Pollock
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.